{
    "eid": "2-s2.0-85137399644",
    "title": "Homologous or Heterologous COVID-19 Booster Regimens Significantly Impact Sero-Neutralization of SARS-CoV-2 Virus and Its Variants",
    "cover-date": "2022-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "booster",
        "COVID-19",
        "neutralization",
        "vaccine",
        "variants of concern"
    ],
    "authors": [
        "Rome Buathong",
        "Taweewun Hunsawong",
        "Supaporn Wacharapluesadee",
        "Suriya Guharat",
        "Ratthapat Jirapipatt",
        "Sasiprapa Ninwattana",
        "Nattakarn Thippamom",
        "Anusara Jitsatja",
        "Anthony R. Jones",
        "Kamonthip Rungrojchareonkit",
        "Jindarat Lohachanakul",
        "Rungarun Suthangkornkul",
        "Kedsara Tayong",
        "Chonticha Klungthong",
        "Stefan Fernandez",
        "Opass Putcharoen"
    ],
    "citedby-count": 3,
    "ref-count": 18,
    "ref-list": [
        "Early Dynamics of Transmission and Control of COVID-19: A Mathematical Modelling Study",
        "SARS-CoV-2 Vaccines in Development",
        "COVID-19 Vaccine Effectiveness in New York State",
        "Effect of COVID-19 Vaccination on Transmission of Alpha and Delta Variants",
        "Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance",
        "Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine",
        "Short-Term Immune Response after Inactivated SARS-CoV-2 (CoronaVac\u00ae, Sinovac) and ChAdOx1 NCoV-19 (Vaxzevria\u00ae, Oxford-AstraZeneca) Vaccinations in Health Care Workers",
        "Heterologous AD5-NCOV plus CoronaVac versus Homologous CoronaVac Vaccination: A Randomized Phase 4 Trial",
        "Escape of SARS-CoV-2 501Y.V2 from Neutralization by Convalescent Plasma",
        "Molecular Basis of Immune Evasion by the Delta and Kappa SARS-CoV-2 Variants",
        "SARS-CoV-2 501Y.V2 Escapes Neutralization by South African COVID-19 Donor Plasma",
        "Protection by a Fourth Dose of BNT162b2 against Omicron in Israel",
        "Increased Immune Escape of the New SARS-CoV-2 Variant of Concern Omicron",
        "Efficacy of a Fourth Dose of COVID-19 MRNA Vaccine against Omicron",
        "Evaluation of SARS-CoV-2 Neutralizing Antibodies Using a CPE-Based Colorimetric Live Virus Micro-Neutralization Assay in Human Serum Samples",
        "Neutralizing Antibody Responses Elicited by SARS-CoV-2 MRNA Vaccination Wane over Time and Are Boosted by Breakthrough Infection",
        "Emerging SARS-CoV-2 Variants of Concern Evade Humoral Immune Responses from Infection and Vaccination",
        "Booster Dose of BNT162b2 after Two Doses of CoronaVac Improves Neutralization of SARS-CoV-2 Omicron Variant"
    ],
    "affiliation": [
        {
            "affiliation-city": "Nontaburi",
            "@id": "60015728",
            "affilname": "Thailand Ministry of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015728",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016185",
            "affilname": "Armed Forces Research Institute of Medical Sciences, Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016185",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "AFHSC-GEIS",
        "Armed Forces Health Surveillance Center",
        "Division of Global Emerging Infections Surveillance",
        "NIAID-CREID",
        "National Institute of Health",
        "National Institute of Allergy and Infectious Diseases",
        "WHO",
        "King Chulalongkorn Memorial Hospital",
        "European Union",
        "National Research Council of Thailand"
    ]
}